keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Apelin-13 triTFA(217082-58-1(free base)) 是 APJ 受体的内源性配体,可激活该 G 蛋白偶联受体,EC50 值为 0.37 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 721 | 现货 | ||
2 mg | ¥ 1,110 | 现货 | ||
5 mg | ¥ 1,450 | 现货 | ||
10 mg | ¥ 2,480 | 现货 | ||
25 mg | ¥ 4,190 | 现货 | ||
50 mg | ¥ 5,970 | 现货 | ||
100 mg | ¥ 8,270 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 3,880 | 现货 |
产品描述 | Apelin-13 triTFA is the endogenous ligand of the APJ receptor, activating this G protein-coupled receptor with an EC50 value of 0.37 nM. |
体内活性 | Apelin-13 highly increased AQP4 expression as well as reduced neurological scores and infarct volume.?Importantly, Apelin-13 played a role of BBB protection in both types of mice by reducing BBB permeability, increased vascular endothelial growth factor, upregulated endothelial nitric oxide synthase, and downregulated inducible NOS. In morphology, we demonstrated Apelin-13 suppressed tight junction opening and endothelial cell swelling via electron microscopy detection.?Meanwhile, Apelin-13 also alleviated apoptosis of astrocytes and promoted angiogenesis[1].?Apelin 13 treatment significantly reduced infarct size, improved neurological outcomes, decreased brain edema, and inhibited cell apoptosis, oxidative stress, and neuroinflammation after I/R. Apelin 13 significantly increased the expression of Nrf2 and the phosphorylation levels of AMPK and GSK-3β[2]. |
动物实验 | The expression of AQP4 induced by Apelin-13 injection at 1, 3, and 7 days after middle cerebral artery occlusion.?Meanwhile, examined the effects of Apelin-13 on neurological function, infarct volume, and BBB disruption owing to cerebral ischemia in wild type mice, and tested whether such effects were AQP4 dependent by using AQP4 knock-out mice[1]. |
分子量 | 1892.89 |
分子式 | C75H114F9N23O22S |
CAS No. | T7847 |
keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (15.85 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 0.5283 mL | 2.6415 mL | 5.2829 mL | 13.2073 mL |
5 mM | 0.1057 mL | 0.5283 mL | 1.0566 mL | 2.6415 mL | |
10 mM | 0.0528 mL | 0.2641 mL | 0.5283 mL | 1.3207 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Apelin-13 triTFA(217082-58-1(free base)) T7847 Others Apelin 13 triTFA(217082 58 1(free base)) Apelin13 triTFA(217082581(free base)) Inhibitor inhibitor inhibit